Annandale Capital »

Cue Biopharma shares owned by Annandale Capital

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $172k 65k 2.65
2023-09-30 $150k 65k 2.31
2023-06-30 $237k 65k 3.65
2023-03-31 $232k 65k 3.57
2022-12-31 $185k 65k 2.85
2022-09-30 $145k 65k 2.23